Tocilizumab and steroid boli for treatment-resistant anterior necrotizing scleritis

Acta Ophthalmologica

Volumn 93, Issue 8, 2015, Pages e683-e684

  Tode, Jan ^a   Zeuner, Rainald ^a   Saeger, Mark ^a   Roider, Johann ^a   Nölle, Bernhard ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; METHYLPREDNISOLONE; PREDNISOLONE; STEROID; TOCILIZUMAB; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ADULT; ANTERIOR NECROTIZING SCLERITIS; CASE REPORT; DRUG DOSE REDUCTION; DRUG RESPONSE; EYE PAIN; FEMALE; HEADACHE; HUMAN; IRIDOCYCLITIS; LETTER; MIDDLE AGED; NECROSIS; PRIORITY JOURNAL; SCLERITIS; VISUAL ACUITY; COMBINATION DRUG THERAPY; DRUG EFFECTS; DRUG RESISTANCE; PATHOPHYSIOLOGY;

ANTIBODIES, MONOCLONAL, HUMANIZED; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; PREDNISOLONE; SCLERITIS; VISUAL ACUITY;

EID: 84955704318     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12720     Document Type: Letter

References (5)

1. Lin P, Suhler EB, &, Rosenbaum JT, (2014): The future of uveitis treatment. Ophthalmology 121: 365-376.
2. McCluskey P, &, Wakefield D, (1987): Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol 105: 793-797.
3. Murphy CC, Ayliffe WH, Booth A, Makanjuola D, Andrews PA, &, Jayne D, (2004): Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 111: 352-356.
4. Rachitskaya A, Mandelcorn ED, &, Albini TA, (2012): An update on the cause and treatment of scleritis. Curr Opin Ophthalmol 21: 463-467.
5. Tappeiner C, Heinz C, Ganser G, &, Heiligenhaus A, (2012): Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis? J Rheumatol 39: 1294-1295.